Retraction to: Development of novel anti-Kv 11.1 antibody-conjugated PEG–TiO2 nanoparticles for targeting pancreatic ductal adenocarcinoma cells (Journal of Nanoparticle Research, (2013), 15, 12, (2111), 10.1007/s11051-013-2111-6)

Abstract

The Editor-in-Chief has retracted this article after an investigation by Sorbonne Paris Nord University and CNRS revealed that the histogram published in the Correction [1] is not compatible with the size of the nanoparticles shown in the ME images and the characteristics of the XRD spectrum do not reflect the size of the nanoparticles. The Editors have therefore lost confidence in the findings of this article. J. Spadevecchia does not agree to this retraction. J. Landoulsi, O. Crociani, and A. Arcangeli did not respond to correspondence from the Editor about this retraction. The Editor was unable to establish the current email addresses for A. Setti, S. Casale, and B. Haye.